Seelos Therapeutics, Inc.
SEEL · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,710 | -$2,664 | -$5,453 | $10,498 |
| Dep. & Amort. | $15 | $15 | $15 | $14 |
| Deferred Tax | $0 | $0 | $5,548 | -$23,906 |
| Stock-Based Comp. | $872 | $955 | $964 | $974 |
| Change in WC | $1,303 | $456 | $5,128 | $5,872 |
| Other Non-Cash | -$4,872 | -$3,404 | -$8,113 | $799 |
| Operating Cash Flow | -$972 | -$4,642 | -$1,911 | -$5,749 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$185 | -$1,314 | $0 | $0 |
| Stock Issued | $927 | $3,480 | $4,477 | $4,343 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $4 | -$2,154 | $2,490 |
| Financing Cash Flow | $742 | $2,170 | $2,323 | $2,490 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$230 | -$2,472 | $412 | -$3,259 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $524 | $2,996 | $2,584 | $5,843 |
| End Cash | $294 | $524 | $2,996 | $2,584 |
| Free Cash Flow | -$972 | -$4,642 | -$1,911 | -$5,749 |